Primary injection sites for AOD-9604 include the abdominal area (around the navel, varying position each injection), the front of the thighs (alternating legs), and the back of the upper arms (alternating arms)
It inhibits growth but does not sterilize
Egr, Nos, Srf, Vegfr, Akt1, Plc , and Kras pathways (Vukojevic et al., 2018)
AOD9604 serves as a valuable research tool for investigating growth hormone fragment biology and selective metabolic effects dissociated from classical GH receptor-mediated actions
Expedited Options: Faster methods available at checkout
[4] Pharmacokinetics and Distribution Pharmacokinetic work in mice reported systemic exposure and distribution of 5-Amino-1MQ to metabolically active tissues, including adipose, muscle, and liver, after subcutaneous compound application